ClinicalTrials.gg
CompletedNCT05974956MastitisUpdated Aug 3, 2023

Effect of a Nursing Teaching Protocol on Mastitis Prognosis: Quasi-Experimental Research Design

An interventional study of Mastitis care teaching protocol in Mastitis, sponsored by Assiut University. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-03.

Sponsored by Assiut University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Apr 2022, registered Jul 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
20 Years to 65 Years
Sex
Female
01

Study summary

Aim: Evaluate the effect of a nursing teaching protocol on mastitis prognosis. Research design: Quasi-experimental research design was utilized. A convenient sample of sixty adult female patients diagnosed with mastitis, Patients divided equally into two groups(study and control) thirty for each.

Read the detailed description

The study was conducted in the breast unit in general surgery department at Main Assiut University Hospital. A convenient sample of sixty adult female patients diagnosed with mastitis, their ages range from 20 to 65years old. Patients divided equally into two groups; thirty for each. Both groups had been assessed at base line using the following tools:

Tool (I): An interview questionnaire sheet Tool (II):Mastitis self-care practices Tool (III): Numeric pain rating scale Tool (IV): Mastitis prognosis sheet

The control group exposed to routine care and study group received mastitis teaching protocol. After three weeks; both groups had been reassessed by the same tools.

Data analysis had been performed by using the Statistical Package for the Social Sciences (SPSS) Categorical variables described by number and percent (N, %). Continuous variables described by mean and standard deviation (Mean, SD). Chi-square test and Fisher exact test used to compare between categorical variables .T-test and Pearson's chi-square used to appear the association between patients' knowledge, practice, and mastitis prognosis before implementation of nursing teaching protocol and three weeks post.

02

Conditions studied

  • Mastitis

Browse trials for

03

In context

Mastitis

31 studies on the registry are indexed under Mastitis; 7 are open to participants now.

This study's enrollment of 60 is below the median of 114 across 16 interventional studies indexed under Mastitis.

Browse Mastitis studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Exclusion Criteria:

  1. Mental health problems
  2. Visual or hearing problems
  3. Uncooperative
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • No intervention
    Control group

    The control group exposed to routine care.

  • Experimental
    Study group

    The study group received the sessions of "mastitis care teaching protocol".

    Other: Mastitis care teaching protocol

Interventions

  • OtherMastitis care teaching protocol

    It was developed by the authors based on previous similar studies, articles and library resources. It was introduced to the study group in the form of face to face sessions plus a hand out copy. It consisted of three parts; (1): Theoretical part about mastitis (definition, types, clinical manifestation, possible causes, diagnosis and management). (2):Self-care practices, and (3):Recommendations regarding dietary measures, rest, medication and follow up.

06

What researchers measure

Primary outcomes

  1. Compare the difference between the mean knowledge of participants (study and control groups) regarding mastitis care and management at base line & follow up after three weeks.

    The knowledge of participants(study and control groups) regarding mastitis care and management had been assessed twice( base line - follow up) using: Tool I: An interview questionnaire sheet (part 2) Tool I: It was structured by authors and reviewed by a panel of experts in General Surgery and Medical -Surgical Nursing. Each answered question scored from 0 to 3 marks as follows; 3 marks for complete correct answer, 2 marks for incomplete correct answer, 1 mark for incorrect answer and zero for not known answer. The range of total score lies between 0-30, the scoring system interpreted in the results into satisfactory and unsatisfactory; satisfactory: if the total knowledge score is ≥ 60% and unsatisfactory if the total knowledge score is \< 60%.

    Time frame: Base line assessment: Is the first assessment --------- Follow up assessment:: after three weeks

  2. Compare the difference between the mean practice of participants (study and control groups) regarding mastitis care and management at base line & follow up after three weeks.

    The performance of participants (study and control groups) regarding mastitis care and management had been assessed twice (baseline- follow up) using: Tool II: "Mastitis self-care practices". Tool II: It was structured by authors and reviewed by a panel of experts in General Surgery and Medical -Surgical Nursing. Scoring: A total score of 60% or higher considered as adequate self-care practices and less than 60% considered as inadequate. Three points scale used to grade the steps. Two points for doing correctly. One point for doing incorrectly and zero point for not doing at all.

    Time frame: Base line assessment: Is the first assessment --------- Follow up assessment:: after three weeks

Secondary outcomes

  1. Pain level using Numeric Pain Rating scale

    Pain level as a symptom of mastitis was measured at base line using Tool III: Numeric Pain rating scale for both study and control groups. It was asked from each patient to rate pain level from 0 to10 with understanding that 0 is equal to no pain and 10 is equal to worst possible pain. At follow up "third week" pain level was measured again for both study and control groups with the same scale to test for change.

    Time frame: Base line assessment: Is the first assessment --------- Follow up assessment:: after three weeks

  2. Number of participants(study -control) who discontinued breast feeding

    Lactating women in either groups (study -control) reported that they discontinued nursing their babies. This outcome was evaluated by using tool IV: "Mastitis prognosis sheet" that had been structured by authors and reviewed by a panel of experts in General Surgery and Medical -Surgical Nursing.

    Time frame: At the third week from base line assessment.

  3. Number of participants (study -control) who completely cured from mastitis

    Inflamed breast was evaluated for both groups (study- control), If it resolved and returned to normal condition or not. This outcome was evaluated clinically (signs \& symptoms) by using tool IV: "Mastitis prognosis sheet" that had been structured by authors and reviewed by a panel of experts in General Surgery and Medical -Surgical Nursing.

    Time frame: At the third week from base line assessment.

  4. Number of participants (study -control) who their condition complicated with formation of breast abscess.

    Breast abscess is a complication of mastitis that will be formed within the inflamed breast tissue. This outcome was evaluated clinically (signs and symptoms) by using tool IV: "Mastitis prognosis sheet" that had been structured by authors and reviewed by a panel of experts in General Surgery and Medical -Surgical Nursing.

    Time frame: At the third week from base line assessment.

  5. Number of mastitis recurrence among participants(study -control) .

    The inflamed breast tissue re-inflamed again for the second time. This outcome was evaluated clinically (signs and symptoms) by using tool IV: "Mastitis prognosis sheet" that had been structured by authors and reviewed by a panel of experts in General Surgery and Medical -Surgical Nursing.

    Time frame: At the third week from base line assessment.

07

Study locations

1 site
  • Faculty of Nursing
    Assiut, 71111, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — Yes: There is a plan to make IPD and related data dictionaries available.

Supporting information: Statistical analysis plan, Clinical study report

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05974956
Lead sponsor
Assiut University
Responsible party
Amna A. Desouky, MD (Assistant professor of Medical Surgical Nursing, Assiut University) — Principal investigator
First posted
Aug 3, 2023
Start date
Apr 1, 2022
Primary completion
Nov 30, 2022
Completion
Apr 30, 2023
Last update
Aug 3, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion